Oncolytic viruses (OVs) preferentially infect and selectively replicate in cancer cells. OVs have been tested in clinical trials as monotherapy or in combination with chemotherapy, radiotherapy, and immunotherapy. However, the dense extracellular matrix hampers the intratumoral spreading and efficacy of OVs. Previously we described VCN-01, an oncolytic adenovirus expressing a soluble version of human sperm hyaluronidase (hyal) PH20, which exhibited enhanced intratumoral distribution and antitumor activity in different models. Here, we present two oncolytic adenoviruses designed to increase the secretion of PH20 compared to VCN-01. ICO15K-40SAPH20, encoding PH20 under an Ad40 splice acceptor, and ICO15K-E1aPH20 expressing PH20 fused to the gene by P2A peptide. We demonstrate that increased hyal activity improves antitumor efficacy in both a sensitive immunodeficient model and an immunocompetent model. Moreover, we show that hyal activity impacts T cell accumulation in tumors, highlighting the value of a hyaluronidase-expressing virus for combinations with other immunotherapies in cancers involving dense stroma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321894 | PMC |
| http://dx.doi.org/10.1016/j.omto.2021.05.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Berberine attenuates ECM accumulation and the progression of acute liver failure through inhibition of NLRP3 inflammasome signalling.
Toxicol Appl Pharmacol
November 2024
Laboratory of Molecular NeuroTherapeutics, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Uttar Pradesh 226002, India; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Uttar Pradesh 226002, India. Electronic address:
Acute liver failure (ALF) is a life-threatening disease, characterized by upregulated extracellular matrix deposition and inflammatory signalling, with no effective treatment options and targets. The present study was designed to investigate the preventive and therapeutic effects of berberine (BBR) and its underlying mechanism in thioacetamide (TAA)-induced ALF. Male SD rats were administered with TAA 300 mg/kg, i.
View Article and Find Full Text PDFInhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose.
Sci Transl Med
September 2024
Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Article Synopsis
- Hepatic stellate cells (HSCs) play a crucial role in the development of liver fibrosis, and the enzyme CYP1B1 is found to be elevated in fibrotic liver tissue in both humans and mice.
- Targeted inhibition or removal of CYP1B1 in mice reduced HSC activation and provided protection against liver fibrosis caused by various damaging substances, particularly in male mice.
- The study highlights trehalose, a disaccharide that increases in CYP1B1-deficient HSCs, as a potential antifibrotic agent, suggesting that inhibiting CYP1B1 or using trehalose derivatives could lead to new treatments for liver fibrosis.
Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
Int Immunopharmacol
December 2024
Department of Life Sciences, University of Science and Technology of Hanoi (USTH), Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam. Electronic address:
Article Synopsis
- Immunogenic cell death (ICD) is a process that includes various forms of cell death like apoptosis and necroptosis, which helps stimulate an immune response against cancer cells by utilizing damage signals and tumor-associated antigens.
- ICD is a promising strategy in cancer immunotherapy because it can both directly kill cancer cells and promote long-lasting immune reactions against tumors, and traditional therapies like radiation and chemotherapy can also induce ICD to enhance their effectiveness.
- The use of nanoparticles in cancer therapy is highlighted as a key development for inducing ICD safely and effectively, as they improve the delivery of treatment, target cancer sites better, and reduce side effects compared to conventional therapies.
Advances and challenges in anti-cancer vaccines for multiple myeloma.
Front Immunol
August 2024
Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.
Multiple myeloma (MM) is a hematological cancer marked by plasma cell accumulation in the bone marrow. Despite treatment advancements, MM remains incurable in most patients. MM-associated immune dysregulation fosters disease progression, prompting research into immunotherapy to combat the disease.
View Article and Find Full Text PDFSpecnuezhenide ameliorates hepatic fibrosis via regulating SIRT6-Mediated inflammatory signaling cascades.
J Ethnopharmacol
December 2024
College of Pharmacy, Beihua University, Jilin, Jilin Province 132013, PR China. Electronic address:
Ethnopharmacological Relevance: Ligustrum lucidum W.T. Aiton is a traditional Chinese medicine that has long been used with high hepatoprotective therapeutic and condition value.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!